✨ Health Notices




3304 NEW ZEALAND GAZETTE, No. 127 22 NOVEMBER 2007

Health

Crown Entities Act 2004

Appointment to the Crown Health Financing Agency

Pursuant to section 28(1)(a) of the Crown Entities Act 2004, I have appointed

Andrew John Anderson (known as John Anderson)

as a member of the board of the Crown Health Financing Agency for a three-year term of office commencing on 13 November 2007 and expiring on 12 November 2010.
This appointment was made by way of written notice to the member (with a copy to the entity), pursuant to section 28(2) of the Crown Entities Act 2004.

Dated at Wellington this 12th day of November 2007.

HON. DAVID CUNLIFFE, Minister of Health.

go8074

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Budenocort 200
Active Ingredient: Budesonide 200Β΅g/dose
Dosage Form: Powder for inhalation
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Medochemie Limited, Ayios Athanassios Industrial Estate, Limassol, Cyprus

Product: Budenocort 400
Active Ingredient: Budesonide 400Β΅g/dose
Dosage Form: Powder for inhalation
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Medochemie Limited, Ayios Athanassios Industrial Estate, Limassol, Cyprus

Product: DP-Anastrozole
Active Ingredient: Anastrozole 1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Douglas Manufacturing Limited, Lincoln, Auckland

Dated this 14th day of November 2007.

ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8003

Consent to the Distribution of New Related Products

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related products set out in the Schedule hereto:

Schedule

Product: Macleans White and Shine Berry Fresh
Active Ingredient: Sodium fluoride 0.221%w/w
Dosage Form: Toothpaste
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Australia Pty Limited, Consumer Healthcare, Ermington, New South Wales, Australia

Product: Vicks Vapodrops Honey Fresh
Active Ingredient: Menthol 0.125%w/w
Dosage Form: Lozenge
New Zealand Sponsor: Procter & Gamble Distributing New Zealand
Manufacturer: Procter & Gamble GmbH, Gross Gerau, Germany



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2007, No 127


Gazette.govt.nz PDF NZ Gazette 2007, No 127





✨ LLM interpretation of page content

πŸ₯ Appointment to the Crown Health Financing Agency

πŸ₯ Health & Social Welfare
12 November 2007
Appointment, Crown Health Financing Agency, Board Member
  • Andrew John Anderson, Appointed as a member of the board

  • HON. DAVID CUNLIFFE, Minister of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
14 November 2007
Medicines, Distribution, Consent, Budenocort, DP-Anastrozole
  • ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate

πŸ₯ Consent to the Distribution of New Related Products

πŸ₯ Health & Social Welfare
14 November 2007
Medicines, Distribution, Consent, Macleans, Vicks Vapodrops
  • ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate